May 18, 2007


A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655


Diane Egan
ZOLL Medical Corporation
+1 (978) 421-9637


ZOLL Debuts First and Only "Code-Ready" R Series Defibrillator for Hospitals at 2007 NTI Conference and Exposition

Sunrise  Session Focuses on High Quality CPR

May 18, 2007—CHELMSFORD, MASS.—ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that it will display its range of resuscitation products—including the new ZOLL R Series™ defibrillator—in its booth (#1227) at the 2007 National Teaching Institute and Critical Care Exposition May 22-24 in Atlanta. More than 6,500 critical care nurses are expected to attend.

“We believe the R Series sets a new standard for simplicity and operational readiness, which will improve in-hospital resuscitation efforts,” said Richard A. Packer, President and Chief Executive Officer of ZOLL.  “This exclusive technology delivers new milestones in defibrillator performance and reliability when it counts the most—during a cardiac arrest event.”

ZOLL R Series:   Simple, Smart, Ready

The ZOLL R Series is a Code-Ready™ device that is simple, smart, and ready to use. It offers a OneStep™ system to simplify and speed up deployment of pacing and defibrillation therapy. It also offers smart tools to help clinicians improve CPR performance, which is important since more than half of in-hospital codes involve non-shockable rhythms and, in such cases, the only treatment is high-quality CPR with minimal interruptions.

The R Series can also verify the condition and expiration date of the electrode set. All of this testing occurs without disconnecting electrodes or paddles, or requiring additional equipment to test shock delivery. The system provides a printed or electronic log to alert hospital personnel of any concerns in advance of a code. A simple green checkmark indicates that the R Series is fully ready for use.

ZOLL Sponsors Sunrise Session on High Performance CPR

In keeping with ZOLL’s vision to help improve CPR quality and increase survival rates, ZOLL will hold a breakfast symposium on  May 22 entitled “High Performance CPR—Impacting Patient Outcomes”, featuring leading resuscitation expert and author Dana Peres Edelson, M.D. The session will review the components of high quality CPR by presenting clinical data on compression rate and depth, as well as the impact of interruptions and excessive ventilations, and how these factors influence patient outcomes.  The session will also cover the tools available to improve the quality of in-hospital CPR including feedback and automatic compressions. 

CPR Challenge

ZOLL invites exhibition attendees to participate in the CPR Challenge using the AED Pro and AED Plus defibrillators in Booth #1227. Every hour, ZOLL will award prizes to attendees with the highest percentage of compressions in target (i.e., best rate and depth of chest compressions) that would be effective in helping maintain blood flow to the brain and heart of a cardiac arrest victim.

In addition to the R Series, ZOLL will also display the following products: 

  • ZOLL CodeNet®, which is the first software system that allows hospital teams to better document, manage, and review cardiac arrest event and resuscitation information. CodeNet brings new improvements and efficiencies in data capture, event time synchronization, and case and aggregate reporting. It is the only system that time stamps logged events and synchronizes these times with defibrillator data, providing clinicians with a complete and accurate timeline of an entire cardiac arrest event.
  • The ZOLL M Series® CCT, which offers ZOLL’s superior biphasic defibrillation, external pacing, complete monitoring, and a large full-color display in a single portable unit. The M Series CCT features a three-channel display for ECG and two invasive pressures with ranges covering arterial, pulmonary arterial, central venous, or intracranial, as well as two temperature channels. It also provides all the non-invasive parameter options including SpO2, EtCO2, NIBP, and fully interpretive 12-lead ECG. 
  • The AutoPulse®, which is an automated, non-invasive cardiac support pump. Its unique, load-distributing LifeBand® squeezes a wide surface area of the chest, helping to move more blood, more effectively than is possible with human hands.
  • Its line of automated external defibrillators (AEDs), the ZOLL AED Plus® and AED Pro® with Real CPR Help™. ZOLL’s Real CPR Help, first available in 2002, allows rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions.

ZOLL St.  Bernard

ZOLL’s popular rescue dog will also be available for photos  with attendees.  Participants will  be able to download the photo from ZOLL’s website on their return home.   

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.

Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on May 11, 2007.

©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. Code-Ready, OneStep, R Series, and Real CPR Help are trademarks of ZOLL Medical Corporation. AED Plus, AED Pro, AutoPulse, CodeNet, LifeBand, M Series, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.